Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Samsung Bioepis
Manufacturing
Manufacturing will be separator for Humira biosims, AbbVie says
Among the firms coming with biosimilars to challenge Humira, the ones with the most reliable manufacturing will win favor from payers, AbbVie says.
Kevin Dunleavy
Sep 20, 2022 8:50am
Daiichi-Seagen, Roche-Jemincare, AbbVie-I-Mab—Fierce Pharma Asia
Aug 19, 2022 9:35am
Roche's Vabysmo a major threat to Regeneron's Eylea, survey says
Jun 13, 2022 10:34am
Takeda, Biogen-Samsung, Astellas and more—Fierce Pharma Asia
Jun 3, 2022 10:05am
Biogen launch first US biosimilar with Samsung Bioepis
Jun 2, 2022 8:00am
Roche's Vabysmo to offer 'fierce competition' to Eylea
Mar 7, 2022 10:52am
